BPC-157 Dosage: Animal Doses, Human Reports, Syringe Units
BPC-157 dosage chart: the community protocols on this page laid out week by week, and how many units each injection is on a U-100 insulin syringe at the two vial and water combinations that keep a 250 mcg dose readable. Doses are per injection and in micrograms; none of them is validated in a human trial.
| Week | Dose | Units on a U-100 syringe, 5 mg vial in 2 mL (2.5 mg/mL) | Units on a U-100 syringe, 10 mg vial in 5 mL (2 mg/mL) | Notes |
|---|---|---|---|---|
| Weeks 1 to 2 (acute injury) | 250 mcg twice daily | 10 | 12.5 | 500 mcg a day, split; subcutaneous, or intramuscular near the site |
| Weeks 3 to 4 | 250 mcg once or twice daily | 10 | 12.5 | End of the usual two to four week block for an acute soft tissue injury |
| Weeks 5 to 8 (tendon, ligament) | 250 to 500 mcg daily | 10 to 20 | 12.5 to 25 | Slow tissue runs six to eight weeks; the dose barely changes, the duration does |
| General recovery | 200 to 300 mcg daily | 8 to 12 | 10 to 15 | Four weeks alongside training, repeated as needed |
| Gut complaints | 250 to 500 mcg daily | n/a | n/a | Oral is the common route here, so no syringe; four to eight weeks |
Units on your syringe: the two unit columns assume the vial and water shown in each heading, and a U-100 insulin syringe where 100 units is 1 mL. For any other vial size or water volume, the BPC-157 calculator on peptulator.com gives the exact mark for your mix.
Best vendor for BPC-157 right now: Amino Club, Code 100: 20% off.
Bureau Score 4.7, 0 of 1 independent tests passed (Finnrick). Compare every store. Black Friday 2026 vendor deals. Reader codes were checked on the vendor's cart; offer terms are the vendor's and can change. Affiliate link: we earn a commission if you order. Laboratory research use only, not for human use.
What the animal studies used
Nearly every quoted BPC-157 dose traces back to rodent work. The two doses that recur are 10 mcg/kg and 10 ng/kg, given once daily by intraperitoneal injection, which is how a rat dose is delivered, not how people use it. In the 2003 tendon study the group also tested 10 pg/kg, so the design was checking whether anything happened across a wide range, not looking for an optimum.
| Study (rat, Achilles tendon) | BPC-157 dose and route | Result reported | Human equivalent, FDA method (60 kg adult) |
|---|---|---|---|
| Staresinic 2003, transected Achilles | 10 mcg/kg, 10 ng/kg or 10 pg/kg, intraperitoneal, once daily | Improved load to failure, function score and histology against saline | 10 mcg/kg becomes 1.6 mcg/kg, about 97 mcg. 10 ng/kg becomes about 97 ng |
| Krivic 2008, tendon-to-bone transection | 10 mcg/kg, intraperitoneal, once daily from 30 minutes after surgery | Better early functional recovery, less inflammatory cell influx, more new vessels | About 97 mcg |
How the conversion works. The FDA's July 2005 guidance, Estimating the Maximum Safe Starting Dose in Initial Clinical Trials, scales by body surface area. A rat has a Km factor of 6 and an adult human 37, so the rat dose in mg/kg is divided by 6.2 and then multiplied by 60 kg. The method exists to choose a safe first dose from the dose that caused no harm in animals. It says nothing about which dose works, and it is applied here only to show how far the figures people quote sit from the animal doses.
Best vendor for BPC-157 right now: Amino Club
10mg vial, $39.99 per vial ($4.00 per mg), list price checked 2026-09-08. The vendor Bureau readers order from most, with a batch COA on every product page. Partner code 100 at checkout takes 20% off there, and keeps the order counted for the Bureau. Research use only.
Check price at Amino Club Compare all vendors Black FridayCyber Monday 40% off, applied by our link (was 20%) code 100 ends 30 NovWhat has been reported in humans
A 2026 systematic review searched to 1 June 2026 and found three studies with 30 people between them. It judged all three to be of poor methodological quality and the overall certainty of evidence very low, and concluded that BPC-157 should not be used clinically outside approved trials. An earlier 2025 review in the HSS Journal found 36 studies, 35 of them preclinical, and gave a half-life of under 30 minutes. Neither review found a study comparing doses.
| Report | Design | BPC-157 given | What was reported |
|---|---|---|---|
| Lee and Padgett 2021, knee pain | Retrospective chart review, 17 patients, 16 reached by phone | Intra-articular injection, alone or with thymosin beta-4 | 14 of 16 reported relief; no validated pain or function scale was used |
| Lee 2024, interstitial cystitis | Pilot, 12 women, no response to pentosan polysulfate | 10 mg total, injected around the inflamed bladder area in one procedure | 10 of 12 reported complete resolution; no adverse events reported |
| Lee and Burgess 2025, intravenous safety | Pilot, 2 adults | 10 mg in 250 mL saline on day 1, 20 mg on day 2, each over one hour | No change in tested biomarkers; no side effects reported |
Two points matter for dosing. First, the human doses were single clinic procedures or infusions, not the daily micrograms people inject at home. Second, all three reports share a lead author and none had a control group, so they cannot show that the peptide caused the improvement. The BPC-157 guide covers the mechanism and the animal evidence in more depth, and BPC-157 side effects covers what has and has not been reported.
What users report
Vendor pages and forum posts describe 250 to 500 mcg once or twice daily, usually for two to four weeks for an acute injury and up to six to eight for tendon or ligament. Those figures are reported practice. We found no trial, label or regulator document that supports any of them, they sit about 2.5 to 5 times above the 97 mcg conversion, and nobody has tested whether the difference matters. The weekly chart above lays them out with syringe units, and none of it is validated in a human trial.
Route is also unstudied in people. The rat work used intraperitoneal injection, the human reports used local or intravenous routes, and users describe subcutaneous injection near the site or in abdominal fat. Whether oral BPC-157 does anything is a separate question covered in oral BPC-157. Many users add TB-500, and both compounds are stocked by the same suppliers: Pantheon TB-500 and Apollo TB500 both list it as a direct product, and the stack builder lays out the timing if you are combining more than two things. Block length and spacing are in peptide cycles, and injection technique is in how to inject peptides.
Calculate your draw for BPC-157
Enter the vial strength, the bacteriostatic water you added and your dose, and get the exact mark on the syringe. Free, no signup, and the result comes with a link you can share or save.
Open the BPC-157 calculator peptulator.com, the Bureau's independent toolUnits on a U-100 syringe for 5 mg and 10 mg vials
A U-100 insulin syringe has 100 units per millilitre. Units for a dose equal the dose in mg divided by the concentration in mg/mL, times 100. The 250 mcg and 500 mcg columns below are arithmetic for the two most commonly quoted figures, not recommendations.
| Vial | Water added | Concentration (mg/mL) | mcg per unit | Units for 250 mcg | Units for 500 mcg |
|---|---|---|---|---|---|
| 5 mg | 1 mL | 5 | 50 | 5 | 10 |
| 5 mg | 2 mL | 2.5 | 25 | 10 | 20 |
| 5 mg | 3 mL | 1.67 | 16.67 | 15 | 30 |
| 10 mg | 1 mL | 10 | 100 | 2.5 | 5 |
| 10 mg | 2 mL | 5 | 50 | 5 | 10 |
| 10 mg | 3 mL | 3.33 | 33.33 | 7.5 | 15 |
The row to be wary of is a 10 mg vial in 1 mL, where 250 mcg is 2.5 units and a half-unit misread is a 20 percent error. More water spreads the same dose across more of the barrel without changing the amount of peptide. The error that matters most is unit confusion: 250 mcg is 0.25 mg, and drawing 250 mg would be a thousandfold mistake. For other vial sizes or a BPC-157 and TB-500 blend, the BPC-157 dosage calculator does the sum. Reconstituted peptide storage and handling is in the peptide storage guide.
Not sure which of these you actually need?
Answer five questions about your goal, experience and budget and the Stack Builder shows you a matched research protocol on screen, with the compounds, cycle shape and vendor picks from the vendors we score.
Build your stack, 2 minutesLegal and regulatory status
BPC-157 is not an FDA-approved drug. It is one of the substances the FDA's Pharmacy Compounding Advisory Committee scheduled for discussion on 23 and 24 July 2026, in a session on whether it could be added to the 503A bulk drug substances list; the committee vote page covers the outcome. The 2025 orthopaedic review notes that it is banned in professional sport. Batch purity is a separate risk, which is why the peptide testing guide matters more than the dose. For tendon and joint questions see peptides for tendon repair and peptides for joint pain, and for the companion peptide TB-500 vs BPC-157.
Get the Dispatch
One research note, one vendor deal, once a week. Free dosing guide on confirm.
Double opt-in. Unsubscribe with one click. Research use only.
Vial sizes that make these numbers convenient
A 10mg vial at 250 mcg a day is forty days of material. Both suppliers below list BPC-157 as a direct product page, scored in the 2026 scorecard.
Apollo, BPC157 10mg Pantheon BPC-157Frequently asked questions
What is the BPC-157 dose?
There is no established human dose. No dose-finding trial has been published. The research doses are rodent doses, mostly 10 mcg/kg and 10 ng/kg once daily by injection, and the three small human reports used single clinic procedures of 10 mg or infusions of 10 mg and 20 mg. User-reported protocols of 250 to 500 mcg once or twice daily are not derived from a human trial.
How do you convert a rat BPC-157 dose to a human dose?
The FDA's 2005 guidance divides a rat dose in mg/kg by 6.2 to get a human equivalent dose, which assumes a 60 kg adult. 10 mcg/kg in a rat becomes about 1.6 mcg/kg, or about 97 mcg for 60 kg. The FDA built the method to pick a safe starting dose for first-in-human trials, so it is not an effective dose.
How many units is 250 mcg of BPC-157 on an insulin syringe?
It depends on the vial and the water. A 5 mg vial with 2 mL of water is 2.5 mg/mL, so 250 mcg is 0.1 mL, or 10 units on a U-100 syringe. A 10 mg vial with 2 mL is 5 mg/mL, so the same 250 mcg is 5 units.
How many micrograms are in a 5 mg vial of BPC-157?
5,000 micrograms, because 1 mg is 1,000 mcg. A 10 mg vial holds 10,000 mcg. Confusing milligrams and micrograms is a thousandfold error.
Has BPC-157 been tested in humans?
Only in three small uncontrolled reports, 30 people in total, which a 2026 systematic review rated as very low certainty. They covered knee pain, interstitial cystitis and an intravenous safety check in two adults. A 2025 systematic review found 35 preclinical studies and one clinical study.
Is BPC-157 approved by the FDA?
No. It is not an FDA-approved drug. The FDA's Pharmacy Compounding Advisory Committee scheduled BPC-157 for discussion on 23 and 24 July 2026. Our page on the committee's peptide votes covers the outcome.
Sources
- FDA guidance for industry: Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers, July 2005
- Staresinic et al, gastric pentadecapeptide BPC 157 and transected rat Achilles tendon, J Orthop Res, 2003
- Krivic et al, BPC 157 and methylprednisolone after Achilles tendon-to-bone transection in rats, Inflamm Res, 2008
- Lee and Padgett, intra-articular injection of BPC 157 for multiple types of knee pain, Altern Ther Health Med, 2021
- Lee et al, effect of BPC-157 on symptoms in patients with interstitial cystitis: a pilot study, Altern Ther Health Med, 2024
- Lee and Burgess, safety of intravenous infusion of BPC157 in humans: a pilot study, Altern Ther Health Med, 2025
- Poolton et al, human evidence for BPC-157 in orthopaedic and regenerative medicine: a systematic review, Acta Orthop Belg, 2026
- Vasireddi et al, emerging use of BPC-157 in orthopaedic sports medicine: a systematic review, HSS J, 2025
- McGuire et al, regeneration or risk? A narrative review of BPC-157 for musculoskeletal healing, Curr Rev Musculoskelet Med, 2025
- FDA Pharmacy Compounding Advisory Committee draft agenda, 23 and 24 July 2026
BPC-157 prices by vendor
| Vendor | Vial | Price | Per mg | Ships from | Testing / COA |
|---|---|---|---|---|---|
| Amino Club Readers' pick | 10mg | $39.99 | $4.00 | US | Every batch runs an 8-assay panel at ILS Laboratories |
| Ascension Peptides | 10mg | $49.00 | $4.90 | US | Batch-specific third-party COA |
| Apollo Peptide Sciences | 10mg | $59.99 | $6.00 | US | Third-party tested every batch |
| PSPeptidesCheckout paused since 20 Nov 2026; the store says orders reopen soon. | 5mg | $49.99 | $10.00 | US | Batch-specific COA on every product page |
| Pantheon Peptides | 5mg | $60.00 | $12.00 | US | Every batch tested by an independent lab |
Amino Club list price checked 2026-09-08, the others 2026-09-05; prices change, the link shows the live price. Readers' pick is the vendor Bureau readers have ordered from most this year; code 100 takes 20% off there. PSPeptides prices checked 2026-09-08. Code PEPTIDEBUREAU takes 10% off at PSPeptides and keeps the order counted for the Bureau. Its largest vial is 10mg at $89.99 ($9.00 per mg), which is the cheaper way to buy it there. It is the only vendor here that ships outside the US. Ascension links open the vendor storefront rather than the product page. Bold row is the lowest price per mg among the vendors with a published vial size. Where a vendor sells several vial sizes, the table shows the smallest; larger vials are usually cheaper per mg.
Not sure which of these you actually need?
Answer five questions about your goal, experience and budget and the Stack Builder shows you a matched research protocol on screen, with the compounds, cycle shape and vendor picks from the vendors we score.
Build your stack, 2 minutes